Risk of tuberculosis in a Chinese registry of rheumatoid arthritis and ankylosing spondylitis for tumour necrosis factor‐α antagonists
Open Access
- 12 July 2006
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 9 (2) , 170-174
- https://doi.org/10.1111/j.1479-8077.2006.00193.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The comparative effectiveness of tumor necrosis factor–blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six‐month, longitudinal, observational, multicenter studyArthritis & Rheumatism, 2005
- Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenArthritis & Rheumatism, 2005
- Delayed response to anti-tuberculosis treatment in a patient on infliximabRespiratory Medicine, 2005
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Safety of Tumour Necrosis Factor-?? AntagonistsDrug Safety, 2004
- Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNFAnnals of the Rheumatic Diseases, 2003
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance reportArthritis & Rheumatism, 2003
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999